Arteriosclerosis  >>  dilmapimod (SB-681323)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dilmapimod (SB-681323) / GSK
NCT00291902 / 2005-004285-16: A Pharmacokinetic Study Of SB-681323 In Subjects With Coronary Heart Disease Undergoing Percutaneous Intervention

Completed
2
80
Europe
SB-681323
GlaxoSmithKline
Coronary Heart Disease
 
 

Download Options